Intravenous Artesunate for Severe Malaria in Travelers, Europe
Open Access
- 1 May 2011
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 17 (5), 771-777
- https://doi.org/10.3201/eid1705.101229
Abstract
Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe malaria. We conducted a retrospective analysis for 25 travelers with severe malaria who returned from malaria-endemic regions and were treated at 7 centers in Europe. All patients survived. Treatment with IV artesunate rapidly reduced parasitemia levels. In 6 patients at 5 treatment centers, a self-limiting episode of unexplained hemolysis occurred after reduction of parasitemia levels. Five patients required a blood transfusion. Patients with posttreatment hemolysis had received higher doses of IV artesunate than patients without hemolysis. IV artesunate was an effective alternative to quinine for treatment of malaria patients in Europe. Patients should be monitored for signs of hemolysis, especially after parasitologic cure.Keywords
This publication has 30 references indexed in Scilit:
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Randomized, Double-Blind Study of the Safety, Tolerability, and Efficacy of Tafenoquine versus Mefloquine for Malaria Prophylaxis in Nonimmune SubjectsAntimicrobial Agents and Chemotherapy, 2010
- Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese populationMalaria Journal, 2009
- Severe Malaria and Artesunate Treatment, NorwayEmerging Infectious Diseases, 2008
- One center's experience: the serology and drugs associated with drug‐induced immune hemolytic anemia—a new paradigmTransfusion, 2007
- Immune hemolysis-serological and clinical aspectsClinical and Experimental Medicine, 2003
- Randomized Comparison of Artesunate and Quinine in the Treatment of Severe Falciparum MalariaClinical Infectious Diseases, 2003
- Age as a Risk Factor for Severe Manifestations and Fatal Outcome of Falciparum Malaria in European Patients: Observations from TropNetEurop and SIMPID Surveillance DataClinical Infectious Diseases, 2003
- Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1997
- Detection of cell‐drug (hapten)‐antibody complexes by the gel testTransfusion, 1992